Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
09/25/2013 | CN103315974A Osmotic pump type controlled release preparation containing donepezil and its salt and preparation method thereof |
09/25/2013 | CN103315973A Quetiapine osmotic pump controlled release preparation |
09/25/2013 | CN103315948A Nimodipine polymer blending micelle preparation and preparation method thereof |
09/25/2013 | CN103315584A Drug pillow for regulating blood pressure and inducing sleep |
09/25/2013 | CN103315583A Medical pillow with insomnia prevention and treatment function |
09/25/2013 | CN102813831B Preparation method for traditional Chinese medicine for treating fire excess from yin deficiency type insomnia |
09/25/2013 | CN102793834B Traditional Chinese medicine for treatment of depression |
09/25/2013 | CN102764257B Flupirtine maleate sustained release tablet |
09/25/2013 | CN102727657B Medicament for treating neurasthenia |
09/25/2013 | CN102716084B Fluoxetine hydrochloride liposome solid preparation |
09/25/2013 | CN102641418B Medicament for treating migraine |
09/25/2013 | CN102580000B Medicament for curing cancer pain and preparation method thereof |
09/25/2013 | CN102579989B Flunarizine hydrochloride and preparation process thereof |
09/25/2013 | CN102579720B Medicament for treating facial paralysis and preparation method thereof |
09/25/2013 | CN102579691B Medicinal oil for acupuncture and preparation method thereof |
09/25/2013 | CN102552827B Medicine for treating epilepsy |
09/25/2013 | CN102526592B Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and immune dysfunction |
09/25/2013 | CN102416029B Ginseng submicron powder and preparation method and preparation thereof |
09/25/2013 | CN102349873B Pharmaceutical compositions based on idazoxan salt or one of polymorphs thereof |
09/25/2013 | CN102293886B Chinese medicinal composition for treating insomnia |
09/25/2013 | CN102216271B Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound |
09/25/2013 | CN102028664B Citicoline sodium tablets and preparation method thereof |
09/25/2013 | CN101972471B Application of Ulinastatin in preparing drug for curing autoimmune encephalomyelitis and pharmaceutical composition thereof |
09/25/2013 | CN101743227B Novel histidine derivative |
09/25/2013 | CN101696208B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists |
09/24/2013 | US8541453 Modulators of ATP-binding cassette transporters |
09/24/2013 | US8541446 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof |
09/24/2013 | US8541440 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
09/24/2013 | US8541427 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
09/24/2013 | US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
09/24/2013 | US8541373 BChE albumin fusions for the treatment of cocaine abuse |
09/24/2013 | US8541034 Electrical producing creams |
09/24/2013 | US8540990 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same |
09/24/2013 | CA2745721C Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators |
09/24/2013 | CA2728451C Salicylamide derivatives as nicotinic alpha 7 modulators |
09/24/2013 | CA2708323C 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder |
09/24/2013 | CA2667210C 1,5-diphenyl-3-pyridinylmethylamino-1,5-dihydropyrrolidin-2-one as a cb-1 receptor modulator |
09/24/2013 | CA2611609C Ampa receptor potentiators |
09/24/2013 | CA2608184C N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
09/24/2013 | CA2592345C Piperidine and azetidine derivatives as glyt1 inhibitors |
09/24/2013 | CA2490100C Pharmaceutical formulation for use in treating drug withdrawal and preparation method |
09/24/2013 | CA2488394C Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
09/24/2013 | CA2466697C Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
09/24/2013 | CA2405557C Albumin fusion proteins |
09/19/2013 | WO2013138687A1 Positive allosteric modulators of mglur2 |
09/19/2013 | WO2013138602A1 An iloperidone metabolite for use in the treatment of psychiatric disorders |
09/19/2013 | WO2013138463A1 Neurofibromatoses therapeutic agents and screening for same |
09/19/2013 | WO2013138456A1 Lim kinasemodulating agents for neurofibromatoses therapy and methods for screening for same |
09/19/2013 | WO2013138322A1 Esketamine for the treatment of treatment-refractory or treatment-resistant depression |
09/19/2013 | WO2013137778A1 Solid dosage form having neuroprotector, antiamnesic, antioxidant, antihypoxic, and antiischaemic activity (alternatives) |
09/19/2013 | WO2013137777A1 Pharmaceutical composition having neuroprotector, antiamnesic, antioxidant, antihypoxic, neurometabolic and antiischaemic activity (alternatives) |
09/19/2013 | WO2013137479A1 Decahydroquinoxaline derivatives and analogs thereof |
09/19/2013 | WO2013137371A1 Novel pyrimidine compound and medicine comprising same |
09/19/2013 | WO2013136338A1 Modified kisspeptin peptides and uses thereof |
09/19/2013 | WO2013135596A1 Rho kinase inhibitors for use in treating amyotrophic lateral sclerosis |
09/19/2013 | WO2012107706A8 Phenothiazine diaminium salts and their use |
09/19/2013 | US20130245575 Body product and method of delivery |
09/19/2013 | US20130245128 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
09/19/2013 | US20130245045 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes |
09/19/2013 | US20130245043 Substituted imidazopyrimidin-5(6h)-ones as allosteric modulators of mglur5 receptors |
09/19/2013 | US20130245037 Stabilization of Hypoxia Inducible Factor (HIF) Alpha |
09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
09/19/2013 | US20130244960 Treatment for Alzheimer's Disease |
09/19/2013 | US20130244927 Polynucleotides encoding signal peptide-containing molecules |
09/19/2013 | US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
09/19/2013 | US20130243768 Multimeric proteins and methods of making and using same |
09/19/2013 | US20130243755 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
09/18/2013 | EP2638906A1 Stabilized adhesive preparation containing donepezil |
09/18/2013 | EP2638070A1 Methods and compositions for neural disease immunotherapy |
09/18/2013 | EP2638038A1 Method of treatment for mental disorders |
09/18/2013 | EP2638035A1 Triazole derivatives as ligands for gaba receptors |
09/18/2013 | EP2638031A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators |
09/18/2013 | EP2638029A1 Triazole derivatives and their use for neurological disorders |
09/18/2013 | EP2638009A2 Fluorinated hdac inhibitors and uses thereof |
09/18/2013 | EP2638008A1 Lactam derivatives useful as orexin receptor antagonists |
09/18/2013 | EP2638005A2 S-t-butyl protected cysteine di-peptide analogs and related compounds |
09/18/2013 | EP2637662A1 Dosing regimen for sedation with cns 7056 (remimazolam) |
09/18/2013 | EP2637658A1 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
09/18/2013 | EP2637657A1 Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines |
09/18/2013 | EP2637649A2 Compounds and methods for treating pain |
09/18/2013 | CN1697655B Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
09/18/2013 | CN1694959B Non-sequence complementary antiviral oligonucleotides |
09/18/2013 | CN1630665B Anti-A beta antibodies and their use |
09/18/2013 | CN1578779B Small organic molecule regulators of cell proliferation |
09/18/2013 | CN103313988A Imidazotriazinone compounds |
09/18/2013 | CN103313978A Pyrazole aminopyrimidine derivatives as LRRK2 modulators |
09/18/2013 | CN103313705A Percutaneous absorption preparation containing rivastigmine |
09/18/2013 | CN103305458A Method for inducing cholinergic neurons from pluripotent stem cells |
09/18/2013 | CN103304630A GPCR active polypeptide in scorpion venom of Buthus martensii Karsch, and extracting separation and application thereof |
09/18/2013 | CN103304570A Naloxone hydrochloride compound as well as preparation method and pharmaceutical composition of naloxone hydrochloride compound |
09/18/2013 | CN103304564A Beta-carboline derivative containing hydroximic acid as well as preparation method and medical application thereof |
09/18/2013 | CN103304522A Compound with neuroinflammation inhibition activity, as well as preparation method and application thereof |
09/18/2013 | CN103304483A N-3-arylamine-5-cyclopropane spirohydantoin and preparation method and application thereof |
09/18/2013 | CN103301760A Dissolving method of L-tetrahydropalmatine, L-tetrahydropalmatine solution and application of L-tetrahydropalmatine solution |
09/18/2013 | CN103301475A Natural antisense and non-coding rna transcripts as drug targets |
09/18/2013 | CN103301464A 药物组合物 The pharmaceutical composition of |
09/18/2013 | CN103301461A Long-acting injectable preparation, preparation method and application thereof |
09/18/2013 | CN103301432A Drug for treating lamb crazy |
09/18/2013 | CN103301426A Capsule for invigorating circulation and benefiting heart |
09/18/2013 | CN103301421A Chinese medicine composition for treating sciatica |